ArticleNature cancer2024

Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy.

Yu-Kai Huang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.